Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 54 (1) , 28-39
- https://doi.org/10.1016/j.jinf.2006.01.005
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell linesBiochemical and Biophysical Research Communications, 2004
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJournal of Clinical Virology, 2004
- Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocolRespirology, 2004
- In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compoundsJournal of Clinical Virology, 2004
- Severe acute respiratory syndrome: report of treatment and outcome after a major outbreakThorax, 2004
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004
- Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR ChinaJournal of Medical Microbiology, 2003
- The immunosuppressive potency of various steroids on peripheral blood lymphocytes, T cells, NK and K cellsPublished by Elsevier ,2002
- Relative immunosuppressive potency of various corticosteroids measured in vitroEuropean Journal of Clinical Pharmacology, 1983
- Estimation of Skin Metabolism and Blood Flow with tcPo2and tcPco2Electrodes by Cuff Occlusion of the CirculationActa Anaesthesiologica Scandinavica, 1978